Aflac Incorporated (NYSE:AFL) Shares Sold by OLD National Bancorp IN

OLD National Bancorp IN lessened its stake in Aflac Incorporated (NYSE:AFL) by 0.7% during the second quarter, HoldingsChannel.com reports. The firm owned 19,161 shares of the financial services provider’s stock after selling 131 shares during the period. OLD National Bancorp IN’s holdings in Aflac were worth $1,711,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of AFL. Jaffetilchin Investment Partners LLC raised its stake in Aflac by 1.7% during the first quarter. Jaffetilchin Investment Partners LLC now owns 7,254 shares of the financial services provider’s stock valued at $623,000 after buying an additional 121 shares in the last quarter. Burns Matteson Capital Management LLC lifted its stake in Aflac by 4.1% during the second quarter. Burns Matteson Capital Management LLC now owns 3,077 shares of the financial services provider’s stock worth $275,000 after purchasing an additional 121 shares during the last quarter. Flputnam Investment Management Co. boosted its holdings in Aflac by 0.5% in the fourth quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock worth $2,065,000 after purchasing an additional 122 shares during the period. ICA Group Wealth Management LLC boosted its holdings in Aflac by 4.3% in the fourth quarter. ICA Group Wealth Management LLC now owns 2,974 shares of the financial services provider’s stock worth $245,000 after purchasing an additional 122 shares during the period. Finally, TKG Advisors LLC increased its stake in Aflac by 0.5% during the first quarter. TKG Advisors LLC now owns 24,536 shares of the financial services provider’s stock valued at $2,107,000 after purchasing an additional 122 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Insider Transactions at Aflac

In related news, Director Charles D. Lake II sold 22,378 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the completion of the transaction, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Charles D. Lake II sold 22,378 shares of the firm’s stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the sale, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on AFL shares. Jefferies Financial Group decreased their price target on shares of Aflac from $84.00 to $83.00 and set a “hold” rating for the company in a report on Friday, June 28th. Citigroup lifted their target price on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Bank of America increased their price target on Aflac from $105.00 to $108.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. JPMorgan Chase & Co. boosted their price objective on Aflac from $80.00 to $83.00 and gave the company a “neutral” rating in a research report on Tuesday, July 2nd. Finally, Piper Sandler increased their target price on Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, June 28th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Aflac currently has a consensus rating of “Hold” and a consensus price target of $88.08.

Aflac Price Performance

Aflac stock traded up $0.35 during trading hours on Friday, hitting $101.21. 1,624,233 shares of the company traded hands, compared to its average volume of 2,241,897. Aflac Incorporated has a 1-year low of $72.78 and a 1-year high of $104.90. The firm has a market cap of $57.51 billion, a P/E ratio of 11.17, a P/E/G ratio of 2.76 and a beta of 0.95. The firm’s 50-day simple moving average is $91.92 and its two-hundred day simple moving average is $86.25. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The business had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $4.10 billion. During the same period last year, the firm posted $1.58 earnings per share. The business’s revenue was down .7% on a year-over-year basis. As a group, analysts forecast that Aflac Incorporated will post 6.48 earnings per share for the current fiscal year.

Aflac Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.98%. The ex-dividend date is Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is presently 22.08%.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.